Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis

BACKGROUND: Proton pump inhibitors (PPIs) are usually prescribed to protect against gastrointestinal bleeding in patients on dual antiplatelet therapy. This meta-analysis reviewed clinical outcomes in patients taking aspirin and clopidogrel, with and without concomitant PPIs to address concerns of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wen, Tong, Jin, Kuang, Xue, Chen, Weijie, Liu, Zengzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779765/
https://www.ncbi.nlm.nih.gov/pubmed/29504996
http://dx.doi.org/10.1097/MD.0000000000009638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779765/
https://www.ncbi.nlm.nih.gov/pubmed/29504996
http://dx.doi.org/10.1097/MD.0000000000009638

Ejemplares similares